The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | D | Dermatologicals | |
2 | D07 | Corticosteroids, dermatological preparations | |
3 | D07A | Corticosteroids, plain | |
4 | D07AA | Corticosteroids, weak (group I) |
Code | Title | |
---|---|---|
D07AA01 | Methylprednisolone | |
D07AA02 | Hydrocortisone | |
D07AA03 | Prednisolone |
Active Ingredient | Description | |
---|---|---|
Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
|
Methylprednisolone |
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
|
Prednisolone |
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |
Title | Information Source | Document Type | |
---|---|---|---|
CORTOPIN Cream | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |